Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany

Published:2023-07 Issue: Volume:Volume 15 Page:827-837
ISSN:1179-1349
Container-title:Clinical Epidemiology
language:en
Short-container-title:CLEP

Author:

Voss Annemarie^ORCID,Kollhorst Bianca^ORCID,Platzbecker Katharina^ORCID,Amann Ute^ORCID,Haug Ulrike

Publisher

Informa UK Limited

Subject

Epidemiology

Reference29 articles.

1. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge

2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

3. Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation

4. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

5. Apixaban versus Warfarin in Patients with Atrial Fibrillation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe;BMJ Open;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3